ReviewFrontiers in immunology2025
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors.
Liaoliao Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it